S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
OceanaGold Co. stock logo
OGC
OceanaGold
C$3.19
-1.8%
C$2.83
C$2.08
C$3.50
C$2.26B1.51.45 million shs1.97 million shs
SBM
ProShares Short Basic Materials
$46.38
$46.38
$42.85
$55.15
$1.86MN/A3,024 shsN/A
SLR
Solitario Resources
C$0.97
-1.0%
C$0.79
C$0.65
C$1.00
C$77.25M1.0716,187 shs1,515 shs
10x Genomics, Inc. stock logo
TXG
10x Genomics
$27.94
-3.5%
$40.19
$26.75
$63.57
$3.33B1.91.46 million shs2.08 million shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
OceanaGold Co. stock logo
OGC
OceanaGold
0.00%-2.11%+19.49%+26.46%+235,507,146.38%
SBM
ProShares Short Basic Materials
0.00%0.00%0.00%0.00%-0.01%
SLR
Solitario Resources
-1.01%+3.16%+34.25%+34.25%+11.36%
10x Genomics, Inc. stock logo
TXG
10x Genomics
-0.72%-20.36%-22.66%-30.74%-47.36%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
OceanaGold Co. stock logo
OGC
OceanaGold
1.7538 of 5 stars
2.50.00.80.02.32.51.3
SBM
ProShares Short Basic Materials
N/AN/AN/AN/AN/AN/AN/AN/A
SLR
Solitario Resources
N/AN/AN/AN/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
4.2255 of 5 stars
3.42.00.04.82.43.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
OceanaGold Co. stock logo
OGC
OceanaGold
3.00
BuyC$3.9423.43% Upside
SBM
ProShares Short Basic Materials
0.00
N/AN/AN/A
SLR
Solitario Resources
N/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
2.89
Moderate Buy$60.22115.54% Upside

Current Analyst Ratings

Latest OGC, SBM, TXG, and SLR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$60.00 ➝ $55.00
4/10/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$55.00 ➝ $45.00
4/8/2024
OceanaGold Co. stock logo
OGC
OceanaGold
National Bank Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform Overweight
4/8/2024
OceanaGold Co. stock logo
OGC
OceanaGold
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetC$4.00 ➝ C$4.50
2/29/2024
OceanaGold Co. stock logo
OGC
OceanaGold
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuyC$3.50
2/26/2024
OceanaGold Co. stock logo
OGC
OceanaGold
Cormark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$3.25 ➝ C$3.00
2/23/2024
OceanaGold Co. stock logo
OGC
OceanaGold
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$4.00 ➝ C$3.75
2/22/2024
OceanaGold Co. stock logo
OGC
OceanaGold
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$4.25 ➝ C$3.75
2/16/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$68.00 ➝ $63.00
2/7/2024
OceanaGold Co. stock logo
OGC
OceanaGold
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$4.50 ➝ C$5.00
1/30/2024
OceanaGold Co. stock logo
OGC
OceanaGold
Desjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuyC$3.50 ➝ C$4.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
OceanaGold Co. stock logo
OGC
OceanaGold
C$1.03B2.19N/AN/AC$2.45 per share1.30
SBM
ProShares Short Basic Materials
N/AN/AN/AN/AN/AN/A
SLR
Solitario Resources
C$-408K-189.34C$0.12 per share8.40C$0.33 per share2.94
10x Genomics, Inc. stock logo
TXG
10x Genomics
$618.73M5.38N/AN/A$6.22 per share4.49

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
OceanaGold Co. stock logo
OGC
OceanaGold
C$83.10MC$0.1619.94N/A8.10%4.88%5.49%4/30/2024 (Confirmed)
SBM
ProShares Short Basic Materials
N/AN/A0.00N/AN/AN/AN/AN/A
SLR
Solitario Resources
-C$3.75M-C$0.07N/AN/AN/A-15.77%-10.54%5/14/2024 (Estimated)
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$255.10M-$2.17N/AN/AN/A-41.17%-28.82%-22.67%4/30/2024 (Confirmed)

Latest OGC, SBM, TXG, and SLR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024N/A
OceanaGold Co. stock logo
OGC
OceanaGold
C$0.06N/A-C$0.06N/AN/AN/A
4/30/2024N/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.46N/A+$0.46N/AN/AN/A  
2/21/2024Q4 2023
OceanaGold Co. stock logo
OGC
OceanaGold
C$0.02C$0.01-C$0.01C$0.06N/AC$363.94 million
2/15/2024Q4 2023
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.36-$0.41-$0.05-$0.41$182.73 million$183.98 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
OceanaGold Co. stock logo
OGC
OceanaGold
C$0.030.94%N/A18.75%N/A
SBM
ProShares Short Basic Materials
N/AN/AN/AN/AN/A
SLR
Solitario Resources
N/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest OGC, SBM, TXG, and SLR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2024
OceanaGold Co. stock logo
OGC
OceanaGold
Semi-AnnualC$0.013/6/20243/7/20244/26/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
OceanaGold Co. stock logo
OGC
OceanaGold
13.38
1.05
N/A
SBM
ProShares Short Basic Materials
N/AN/AN/A
SLR
Solitario Resources
0.34
15.73
10.01
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/A
4.69
4.11

Ownership

Institutional Ownership

CompanyInstitutional Ownership
OceanaGold Co. stock logo
OGC
OceanaGold
59.31%
SBM
ProShares Short Basic Materials
N/A
SLR
Solitario Resources
19.36%
10x Genomics, Inc. stock logo
TXG
10x Genomics
84.68%

Insider Ownership

CompanyInsider Ownership
OceanaGold Co. stock logo
OGC
OceanaGold
0.14%
SBM
ProShares Short Basic Materials
N/A
SLR
Solitario Resources
22.69%
10x Genomics, Inc. stock logo
TXG
10x Genomics
10.65%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
OceanaGold Co. stock logo
OGC
OceanaGold
N/A707.38 millionN/AN/A
SBM
ProShares Short Basic Materials
N/A40,000N/ANot Optionable
SLR
Solitario Resources
679.64 millionN/ANot Optionable
10x Genomics, Inc. stock logo
TXG
10x Genomics
1,259119.17 million106.48 millionOptionable

OGC, SBM, TXG, and SLR Headlines

SourceHeadline
10x Genomics (NASDAQ:TXG) Shares Gap Down  on Analyst Downgrade10x Genomics (NASDAQ:TXG) Shares Gap Down on Analyst Downgrade
americanbankingnews.com - April 19 at 1:14 AM
Bruker to acquire Nanostring for $393MBruker to acquire Nanostring for $393M
medtechdive.com - April 18 at 3:02 PM
10x Genomics (NASDAQ:TXG) Shares Gap Down  Following Analyst Downgrade10x Genomics (NASDAQ:TXG) Shares Gap Down Following Analyst Downgrade
marketbeat.com - April 18 at 10:35 AM
10x Genomics (NASDAQ:TXG) PT Lowered to $55.0010x Genomics (NASDAQ:TXG) PT Lowered to $55.00
marketbeat.com - April 18 at 8:34 AM
10x Genomics, Inc. (TXG)10x Genomics, Inc. (TXG)
finance.yahoo.com - April 17 at 12:34 PM
10x Genomics (NASDAQ:TXG) Trading Down 5.9%10x Genomics (NASDAQ:TXG) Trading Down 5.9%
marketbeat.com - April 16 at 1:41 PM
10x Genomics, Inc. (NASDAQ:TXG) Shares Bought by Sumitomo Mitsui Trust Holdings Inc.10x Genomics, Inc. (NASDAQ:TXG) Shares Bought by Sumitomo Mitsui Trust Holdings Inc.
marketbeat.com - April 16 at 7:22 AM
SVB Wealth LLC Has $80.95 Million Position in 10x Genomics, Inc. (NASDAQ:TXG)SVB Wealth LLC Has $80.95 Million Position in 10x Genomics, Inc. (NASDAQ:TXG)
marketbeat.com - April 15 at 10:06 PM
10x Genomics (NASDAQ:TXG) Hits New 52-Week Low at $33.4710x Genomics (NASDAQ:TXG) Hits New 52-Week Low at $33.47
marketbeat.com - April 15 at 2:48 PM
10x Genomics (NASDAQ:TXG) Shares Gap Down  After Analyst Downgrade10x Genomics (NASDAQ:TXG) Shares Gap Down After Analyst Downgrade
americanbankingnews.com - April 12 at 5:26 AM
Cathie Woods ARK focuses on Teladoc and 10X Genomics stockCathie Wood's ARK focuses on Teladoc and 10X Genomics stock
investing.com - April 11 at 7:21 PM
10x Genomics (NASDAQ:TXG) Price Target Cut to $45.00 by Analysts at Barclays10x Genomics (NASDAQ:TXG) Price Target Cut to $45.00 by Analysts at Barclays
americanbankingnews.com - April 11 at 4:58 AM
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 202410x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
finance.yahoo.com - April 10 at 7:03 PM
10x Genomics (NASDAQ:TXG) Price Target Cut to $45.0010x Genomics (NASDAQ:TXG) Price Target Cut to $45.00
marketbeat.com - April 10 at 4:19 PM
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 202410x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
prnewswire.com - April 10 at 4:05 PM
10x Genomics (NASDAQ:TXG) Shares Gap Down to $37.3710x Genomics (NASDAQ:TXG) Shares Gap Down to $37.37
marketbeat.com - April 10 at 11:50 AM
Baillie Gifford & Co. Decreases Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Baillie Gifford & Co. Decreases Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
marketbeat.com - April 9 at 12:12 PM
As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers?As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers?
genengnews.com - March 29 at 5:58 PM
ARK Investment Management LLC Acquires 1,047,827 Shares of 10x Genomics, Inc. (NASDAQ:TXG)ARK Investment Management LLC Acquires 1,047,827 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
marketbeat.com - March 28 at 6:39 AM
10x Genomics, Inc. (NASDAQ:TXG) Shares Acquired by Vanguard Group Inc.10x Genomics, Inc. (NASDAQ:TXG) Shares Acquired by Vanguard Group Inc.
marketbeat.com - March 27 at 4:25 AM
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
finance.yahoo.com - March 26 at 1:11 PM
10x Genomics, Inc: 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel10x Genomics, Inc: 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
finanznachrichten.de - March 23 at 12:22 PM
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
finance.yahoo.com - March 21 at 4:46 PM
TXG Nov 2024 40.000 putTXG Nov 2024 40.000 put
ca.finance.yahoo.com - March 16 at 2:48 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

OceanaGold logo

OceanaGold

TSE:OGC
OceanaGold Corporation, a gold and copper producer, engages in exploration, development, and operation of mineral properties in the United States, the Philippines, and New Zealand. It explores for gold, copper, and silver deposits. OceanaGold Corporation was founded in 2003 and is based in Vancouver, Canada.

ProShares Short Basic Materials

NYSEARCA:SBM
ProShares Short Basic Materials (the Fund) seeks daily investment results that correspond to the inverse (opposite) of the daily performance of Dow Jones U.S. Basic Materials Index (the Index). The Index measures the performance of the basic materials industry of the United States equity market. The Fund invests in derivatives as a substitute for directly shorting stocks in order to gain inverse exposure to the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. The Fund also invests in short-term cash instruments that have terms to maturity of less than 397 days and exhibit credit profiles. ProShare Advisors LLC is the investment advisor of the Fund.

Solitario Resources

TSE:SLR
Solitario Resources Corp., an exploration stage company, engages in the acquisition and exploration of zinc and other base metal properties in North and South America. The company holds a 50% operating interest in the Lik zinc-lead-silver property located in Northwest Alaska; 39% interest in the Florida Canyon zinc project located in northern Peru; and 85% interest in the Chambara exploration project located in Peru. It also holds interest in the Golden Crest project located in western South Dakota, Lawrence County. The company was formerly known as Solitario Zinc Corp. and changed its name to Solitario Resources Corp. in July 2023. Solitario Resources Corp. was incorporated in 1984 and is based in Wheat Ridge, Colorado.
10x Genomics logo

10x Genomics

NASDAQ:TXG
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.